BriannaSmithMD
Pediatric Hematology & Oncology • Nashville, TNCancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology
Physician
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Childrens Way
Nashville, TN 37232Phone+1 615-936-1762Fax+1 615-936-1767
Summary
- Dr. Brianna Smith is a pediatric hematologist/oncologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center.
Education & Training
Vanderbilt University Medical CenterFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Johns Hopkins All Children's HospitalResidency, Pediatrics, 2014 - 2017
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2014
Certifications & Licensure
TN State Medical License 2021 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of PediatricsBoard Certification General Pediatrics
- American Board of PediatricsBoard Certification Pediatric Hematology/Oncology
Clinical Trials
- Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 22 citationsPevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia.Dan Cojocari, Brianna N Smith, Julie J Purkal, Maria Pia Arrate, Jason Huska
Haematologica. 2021-04-15 - 5 citationsSelective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes.Melissa A Fischer, Yuanbin Song, Maria P Arrate, Rana Gbyli, Matthew T Villaume
Haematologica. 2023-02-01 - 2 citationsThe delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T. Villaume, M. Pia Arrate, Haley E. Ramsey, Kathryn I. Sunthankar, Matthew T. Jenkins
Experimental Hematology. 2021-02-19
Grant Support
- Turner Cockrell Discovery GrantTurner's Heroes Foundation2021–2023
- K12 Research Training GrantVanderbilt Clinical Oncology Research Scholars Program2020–2022
- T32 Research Training GrantVanderbilt Integrated Molecular Oncology Research Training Program2018–2020
Professional Memberships
- Member
- Member
- American Society of Pediatric Hematology and Oncology (ASPHO)Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
